Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present NanoString Technologies, Inc. (NASDAQ: NSTG).

Full DD Report for NSTG

You must become a subscriber to view this report.


Recent News from (NASDAQ: NSTG)

NanoString to Present at the Evercore ISI HEALTHCONx Conference
SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2018 Evercore ISI HEALTH...
Source: GlobeNewswire
Date: November, 20 2018 06:00
NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Includes Data from More than Twenty-Five Studies, Including Six Using GeoMx Digital Spatial Profiler SEATTLE, Nov. 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products...
Source: GlobeNewswire
Date: November, 07 2018 16:09
NanoString to Present at the 2018 Canaccord Medical Technologies and Diagnostics Forum
SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2018 Canaccord Medical T...
Source: GlobeNewswire
Date: November, 05 2018 06:00
NanoString Highlights Advances in Product Pipeline and Application Development at the 2018 Association of Molecular Pathology Conference
Demonstrates Potential of Hyb & Seq NGS Platform for Infectious Disease Applications SEATTLE, Oct. 30, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today highligh...
Source: GlobeNewswire
Date: October, 30 2018 06:00
MacroGenics and NanoString collaborates to identify and develop biomarkers in immuno-oncology
NanoString Technologies (NASDAQ: NSTG ) and MacroGenics (NASDAQ: MGNX ) have entered into a translational research agreement to identify and develop biomarkers for MacroGenics’ MGD013 program. More news on: NanoString Technologies, MacroGenics, Inc., Healthcare stocks news, ...
Source: SeekingAlpha
Date: October, 29 2018 07:49
MacroGenics and NanoString Enter Translational Research Collaboration to Identify and Develop Biomarkers in Immuno-Oncology
Translational Research Initiative Will Use PanCancer IO 360 Panel to Identify Predictive Signatures for MGD013 SEATTLE, Oct. 29, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnosti...
Source: GlobeNewswire
Date: October, 29 2018 06:00
Recent Analysis Shows PennyMac Mortgage Investment Trust, Amicus Therapeutics, Children's Place, PLDT, NanoString Technologies, and Worthington Industries Market Influences - Renewed Outlook, Key Drivers of Growth
NEW YORK, Oct. 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of PennyMac Mortgage Investment Trust (NYSE:PMT), Amicus Therapeutics, In...
Source: GlobeNewswire
Date: October, 25 2018 09:25
NanoString Announces $100 Million Term Loan Facility with CRG
SEATTLE, Oct. 15, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a new $100 million term loan facility with the CR Group L.P. (CRG),...
Source: GlobeNewswire
Date: October, 15 2018 09:00
Premarket analyst action - healthcare
Allergan (NYSE: AGN ) initiated with Buy rating and $259 (36% upside) at Guggenheim. More news on: Allergan plc, Bristol-Myers Squibb Company, Merck & Co Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: October, 09 2018 08:14
Landmark Publications in Nature Medicine use NanoString's Digital Spatial Profiling Platform to Discover Novel Insights in Immuno-Oncology
Two Independent Studies Use the GeoMx Digital Spatial Profiler to Investigate the Role of the Tumor and Micro-environment in Immunotherapy Response SEATTLE, Oct. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational...
Source: GlobeNewswire
Date: October, 08 2018 16:01

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-1416.9116.4017.1116.08189,259
2018-12-1317.3917.0517.7616.4519163,416
2018-12-1217.4717.3718.2317.32297,932
2018-12-1117.5017.3217.729917.23155,607
2018-12-1017.0917.4317.4616.6027162,752

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1428,73344,02465.2667Short
2018-12-1311,10240,27927.5627Cover
2018-12-1215,19537,87740.1167Short
2018-12-1114,54429,73748.9088Short
2018-12-1012,44825,53148.7564Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NSTG.


About NanoString Technologies, Inc. (NASDAQ: NSTG)

Logo for NanoString Technologies, Inc. (NASDAQ: NSTG)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: NSTG)

      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 09 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 08 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 26 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 26 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: April, 10 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: March, 20 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 07 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: March, 07 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: February, 13 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: February, 13 2018

       

       


      Daily Technical Chart for (NASDAQ: NSTG)

      Daily Technical Chart for (NASDAQ: NSTG)


      Stay tuned for daily updates and more on (NASDAQ: NSTG)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: NSTG)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NSTG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NSTG and does not buy, sell, or trade any shares of NSTG. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/